ShangPharma prices IPO within range-underwriter

NEW YORK, Oct 18 (Reuters) - ShangPharma Corp priced shares in its initial public offering within the expected range on Monday, according to an underwriter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.